Details of the Drug Formulations

General Information of Drug (ID: DMPIBJK)

Drug Name
Propafenone Drug Info
Synonyms
Propafenona; Propafenonum; Rythmol; Propafenon Hexal; Propafenon hexal (TN); Propafenona [INN-Spanish]; Propafenone (INN); Propafenone [INN:BAN]; Propafenone-HCl; Propafenonum [INN-Latin]; Rythmol SR (TN); Rytmonorm (TN); 1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone; 1-(2-(2-Hydroxy-3-propylaminopropoxy)phenyl)-3-phenylpropan-1-one; 1-[2-(2-Hydroxy-3-(propylamino)propoxy)phenyl]-3-phenyl-1-propanone hydrochloride; 1-[2-(2-Hydroxy-3-[propylamino]-propoxy)phenyl]-3-phenyl-1-propanone; 1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one
Indication
Disease Entry ICD 11 Status REF
Tachyarrhythmias BC71 Approved [1]
Therapeutic Class
Antiarrhythmic Agents
Cross-matching ID
PubChem CID
4932
ChEBI ID
CHEBI:63619
CAS Number
54063-53-5
TTD ID
D0J2KV
VARIDT ID
DR00634
INTEDE ID
DR1361
ACDINA ID
D00562

Full List of Drug Formulations Containing This Drug

Propafenone 225 mg capsule
Company Formulation ID FDA Description
Golden State Medical Supply F18044 Anhydrous lactose; D&c red no. 28; D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Fd&c yellow no. 5; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Water; Alcohol; Crospovidone, unspecified; Ethylcellulose, unspecified; Gelatin, unspecified; Shellac
Par Pharmaceutical F18047 Anhydrous lactose; D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Povidone; Ethylcelluloses; Gelatin; Shellac
Golden State Medical Supply F18045 Anhydrous lactose; D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Ethylcellulose, unspecified; Gelatin, unspecified; Povidone, unspecified; Shellac
American Health Packaging F18046 Anhydrous lactose; D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Alcohol; Ethylcellulose, unspecified; Gelatin, unspecified; Povidone, unspecified; Shellac
AvKARE F18048 Anhydrous lactose; D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Ethylcelluloses; Gelatin; Povidones; Shellac
Actavis Pharma F18042 Sodium lauryl sulfate; Magnesium stearate; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Talc; Titanium dioxide; Gelatin; Hypromelloses; Shellac
Mylan Pharamceuticals F18050 Sodium lauryl sulfate; Magnesium stearate; Ammonia; Ferric oxide red; Ferrosoferric oxide; Titanium dioxide; Silicon dioxide; Ethylcellulose, unspecified; Gelatin, unspecified; Hypromellose, unspecified; Polyethylene glycol, unspecified; Shellac
GlaxoSmithKline; Prasco F18043 Sodium lauryl sulfate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Lecithin, soybean; Gelatin; Hypromelloses; Shellac
Glenmark Pharmaceutials F18049 Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferrosoferric oxide; Potassium hydroxide; Titanium dioxide; Gelatin, unspecified; Hypromellose, unspecified; Microcrystalline cellulose; Shellac
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Formulation(s)
Propafenone 425 mg capsule
Company Formulation ID FDA Description
Par Pharmaceutical F18072 Anhydrous lactose; D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Water; Povidone; Alcohol; Ethylcelluloses; Gelatin; Shellac
AvKARE F18073 Anhydrous lactose; D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Water; Alcohol; Ethylcelluloses; Gelatin; Povidones; Shellac
Golden State Medical Supply F18074 Anhydrous lactose; D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Water; Alcohol; Crospovidone, unspecified; Ethylcellulose, unspecified; Gelatin, unspecified; Shellac
Mylan Pharamceuticals F18076 Sodium lauryl sulfate; Magnesium stearate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Silicon dioxide; Ethylcellulose, unspecified; Gelatin, unspecified; Hypromellose, unspecified; Polyethylene glycol, unspecified; Shellac
Actavis Pharma F18070 Sodium lauryl sulfate; Magnesium stearate; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Talc; Titanium dioxide; Gelatin; Hypromelloses; Shellac
GlaxoSmithKline; Prasco F18071 Sodium lauryl sulfate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Lecithin, soybean; Gelatin; Hypromelloses; Shellac
Glenmark Pharmaceutials F18075 Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferrosoferric oxide; Potassium hydroxide; Titanium dioxide; Gelatin, unspecified; Hypromellose, unspecified; Microcrystalline cellulose; Shellac
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Formulation(s)
Propafenone 325 mg capsule
Company Formulation ID FDA Description
Par Pharmaceutical F18064 Anhydrous lactose; D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Water; Povidone; Alcohol; Ethylcelluloses; Gelatin; Shellac
Rebel Distributors F18067 Anhydrous lactose; D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Propylene glycol; Titanium dioxide; Water; Ethanol; Povidone; Alcohol; Ethylcelluloses; Ferric oxide black; Gelatin; Shellac
Golden State Medical Supply F18063 Anhydrous lactose; D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Water; Alcohol; Crospovidone, unspecified; Ethylcellulose, unspecified; Gelatin, unspecified; Shellac
AvKARE F18065 Anhydrous lactose; D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Water; Alcohol; Ethylcelluloses; Gelatin; Povidones; Shellac
American Health Packaging F18066 Anhydrous lactose; D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Alcohol; Ethylcellulose, unspecified; Gelatin, unspecified; Povidone, unspecified; Shellac
Actavis Pharma F18061 Sodium lauryl sulfate; Magnesium stearate; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Talc; Titanium dioxide; Gelatin; Hypromelloses; Shellac
Mylan Pharamceuticals F18069 Sodium lauryl sulfate; Magnesium stearate; Ammonia; Ferric oxide red; Ferrosoferric oxide; Titanium dioxide; Silicon dioxide; Ethylcellulose, unspecified; Gelatin, unspecified; Hypromellose, unspecified; Polyethylene glycol, unspecified; Shellac
GlaxoSmithKline; Prasco F18062 Sodium lauryl sulfate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Lecithin, soybean; Gelatin; Hypromelloses; Shellac
Glenmark Pharmaceutials F18068 Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferrosoferric oxide; Potassium hydroxide; Titanium dioxide; Gelatin, unspecified; Hypromellose, unspecified; Microcrystalline cellulose; Shellac
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Formulation(s)
Propafenone 150 mg tablet
Company Formulation ID FDA Description
Actavis Pharma; McKesson F18041 Sodium lauryl sulfate; Magnesium stearate; Titanium dioxide; Triacetin; Croscarmellose sodium; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polydextrose; Polyethylene glycols; Starch, corn
NCS HealthCare of KY, Inc dba Vangard Labs F18038 Stearic acid; Lactose; Magnesium stearate; Titanium dioxide; Triacetin; Hypromellose; Povidone; Carnauba wax; Cellulose, microcrystalline; Sodium starch glycolate type a potato; Starch, corn
American Health Packaging F18040 Sodium lauryl sulfate; Magnesium stearate; Titanium dioxide; Triacetin; Croscarmellose sodium; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Hypromellose, unspecified; Microcrystalline cellulose; Polydextrose; Polyethylene glycol, unspecified; Starch, corn
Par Pharmaceutical F18035 Stearic acid; Lactose; Magnesium stearate; Titanium dioxide; Triacetin; Povidone; Carnauba wax; Cellulose, microcrystalline; Hypromelloses; Sodium starch glycolate type a potato; Starch, corn
Bryant Ranch Prepack F18033 Stearic acid; Lactose; Magnesium stearate; Titanium dioxide; Triacetin; Carnauba wax; Cellulose, microcrystalline; Hypromelloses; Povidones; Sodium starch glycolate type a potato; Starch, corn
Physicians Total Care F18039 Magnesium stearate; Propylene glycol; Titanium dioxide; Triacetin; Polysorbate 80; Povidone; Carnauba wax; Hypromelloses; Polydextrose; Polyethylene glycols; Sodium starch glycolate type a potato; Starch, corn
ANI Pharmaceuticals F18036 Maltodextrin; Magnesium stearate; Titanium dioxide; Triacetin; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polydextrose; Polyethylene glycols; Povidones; Starch, corn
Cardinal Health; Mutual Pharmaceutical; Mylan Pharamceuticals F18037 Magnesium stearate; Propylene glycol; Titanium dioxide; Triacetin; Polysorbate 80; Carnauba wax; Hypromelloses; Polydextrose; Polyethylene glycols; Povidones; Sodium starch glycolate type a potato; Starch, corn
GlaxoSmithKline F18034 Magnesium stearate; Propylene glycol; Titanium dioxide; Polysorbate 80; Hypromelloses; Polyethylene glycols; Povidones; Sodium starch glycolate type a potato; Starch, corn
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Formulation(s)
Propafenone 225 mg tablet
Company Formulation ID FDA Description
Actavis Pharma; Avera McKennan Hospital; McKesson F18057 Sodium lauryl sulfate; Magnesium stearate; Titanium dioxide; Triacetin; Croscarmellose sodium; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polydextrose; Polyethylene glycols; Starch, corn
Par Pharmaceutical F18053 Stearic acid; Lactose; Magnesium stearate; Titanium dioxide; Triacetin; Povidone; Carnauba wax; Cellulose, microcrystalline; Hypromelloses; Sodium starch glycolate type a potato; Starch, corn
A-S Medication Solutions F18051 Stearic acid; Lactose; Magnesium stearate; Titanium dioxide; Triacetin; Carnauba wax; Cellulose, microcrystalline; Hypromelloses; Povidones; Sodium starch glycolate type a potato; Starch, corn
Physicians Total Care F18055 Magnesium stearate; Propylene glycol; Titanium dioxide; Triacetin; Polysorbate 80; Povidone; Carnauba wax; Hypromelloses; Polydextrose; Polyethylene glycols; Sodium starch glycolate type a potato; Starch, corn
ANI Pharmaceuticals F18054 Maltodextrin; Magnesium stearate; Titanium dioxide; Triacetin; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polydextrose; Polyethylene glycols; Povidones; Starch, corn
Mutual Pharmaceutical F18056 Magnesium stearate; Propylene glycol; Titanium dioxide; Triacetin; Polysorbate 80; Carnauba wax; Hypromelloses; Polydextrose; Polyethylene glycols; Povidones; Sodium starch glycolate type a potato; Starch, corn
GlaxoSmithKline F18052 Magnesium stearate; Propylene glycol; Titanium dioxide; Polysorbate 80; Hypromelloses; Polyethylene glycols; Povidones; Sodium starch glycolate type a potato; Starch, corn
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Formulation(s)
Propafenone 300 mg tablet
Company Formulation ID FDA Description
Par Pharmaceutical F18058 Stearic acid; Lactose; Magnesium stearate; Titanium dioxide; Triacetin; Povidone; Carnauba wax; Cellulose, microcrystalline; Hypromelloses; Sodium starch glycolate type a potato; Starch, corn
ANI Pharmaceuticals F18059 Maltodextrin; Magnesium stearate; Titanium dioxide; Triacetin; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polydextrose; Polyethylene glycols; Povidones; Starch, corn
Mutual Pharmaceutical F18060 Magnesium stearate; Propylene glycol; Titanium dioxide; Triacetin; Polysorbate 80; Carnauba wax; Hypromelloses; Polydextrose; Polyethylene glycols; Povidones; Sodium starch glycolate type a potato; Starch, corn
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2561).